Alligator Bioscience AB
Biotechnology · Healthcare
CFO
2 appearances
Latest appearance 2026-05-05
CFO
Alligator Bioscience AB
Equibles does not estimate personal net worth.
Johan Gilius is recorded as CFO at Alligator Bioscience AB. Johan Gilius has spoken on 2 earnings calls across 1 company, most recently for Alligator Bioscience AB on May 5, 2026. Alligator Bioscience AB is classified in the Biotechnology industry within the Healthcare sector.
“So here's the snapshot of the Q1 results from from Alligator and we have around 17 million in operating cost and that's mainly then the general operating cost that we have within the organization and we do have some limited initial costs for the planned phase three then, but just a small amount of them.”
“So this is a snapshot of the financials for the Q4 2025, and as expected, we are seeing decreasing expenses due to the fact that we have, you know, more or less closed the clinical trial for phase two, and we also have completed the IMP production as communicated earlier. year.”
Alligator Bioscience AB
CFO
Transcript header (unverified)
Alligator Bioscience AB
Biotechnology · Healthcare
CFO
Interim report Q1 2026
Alligator Bioscience AB
Year-end report 2025
Alligator Bioscience AB